{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["2024"],"submitter":["Kengne MF"],"pubmed_abstract":["<i>Background</i>. Opportunistic infections are the second cause of death among cancer patients. This study aimed at determining the antimicrobial profile and the prevalence of extended-spectrum beta-lactamase (ESBL)-gene carriage of <i>Pseudomonas aeruginosa</i> isolates among cancer patients at the Douala Laquintinie Hospital, Littoral Region of Cameroon. Between October 2021 and March 2023, 507 study participants were recruited among whom 307 (60.55%) were cancer patients, compared to 200 (39.45%) noncancer patients. Fifty-eight <i>P. aeruginosa</i> isolates were isolated from fecal samples of forty-five cancer patients and thirteen noncancer patients using Cetrimide agar. The antimicrobial resistance profile of the isolates was determined using the Kirby-Bauer disk diffusion method. Th"],"journal":["International journal of microbiology"],"pagination":["7685878"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11222006"],"repository":["biostudies-literature"],"pubmed_title":["Frequency of Fecal Carriage of ESBL Resistance Genes in Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Isolates from Cancer Patients at Laquintinie Hospital, Douala, Littoral Region, Cameroon."],"pmcid":["PMC11222006"],"pubmed_authors":["Dadjo BST","Marbou WJT","Karimo O","Tsobeng OD","Kuete V","Mbaveng AT","Kengne MF"],"additional_accession":[]},"is_claimable":false,"name":"Frequency of Fecal Carriage of ESBL Resistance Genes in Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Isolates from Cancer Patients at Laquintinie Hospital, Douala, Littoral Region, Cameroon.","description":"<i>Background</i>. Opportunistic infections are the second cause of death among cancer patients. This study aimed at determining the antimicrobial profile and the prevalence of extended-spectrum beta-lactamase (ESBL)-gene carriage of <i>Pseudomonas aeruginosa</i> isolates among cancer patients at the Douala Laquintinie Hospital, Littoral Region of Cameroon. Between October 2021 and March 2023, 507 study participants were recruited among whom 307 (60.55%) were cancer patients, compared to 200 (39.45%) noncancer patients. Fifty-eight <i>P. aeruginosa</i> isolates were isolated from fecal samples of forty-five cancer patients and thirteen noncancer patients using Cetrimide agar. The antimicrobial resistance profile of the isolates was determined using the Kirby-Bauer disk diffusion method. Th","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024","modification":"2025-04-04T12:55:00.369Z","creation":"2025-04-04T12:55:00.369Z"},"accession":"S-EPMC11222006","cross_references":{"pubmed":["38962396"],"doi":["10.1155/2024/7685878"]}}